Hrt Financial »

Zentalis Pharmaceuticals shares owned by Hrt Financial

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Hrt Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 114k 15.75

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Merck & Co (MRK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Workday Cl A (WDAY)
CRH Ord (CRH)
General Motors Company (GM)
Automatic Data Processing (ADP)
Microsoft Corporation (MSFT)
Raytheon Technologies Corp (RTX)
Illinois Tool Works (ITW)
Johnson Ctls Intl SHS (JCI)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for Hrt Financial

Top funds holding Zentalis Pharmaceuticals

Eventide Asset Management
FMR
BlackRock
Vanguard Group
Citadel Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
Federated Investors
Decheng Capital
MPM Oncology Impact Management
Woodline Partners
Geode Capital Management
Verition Fund Management
Morgan Stanley
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals